BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 9267325)

  • 21. Supplementation with beta-carotene in vivo and in vitro does not inhibit low density lipoprotein oxidation.
    Gaziano JM; Hatta A; Flynn M; Johnson EJ; Krinsky NI; Ridker PM; Hennekens CH; Frei B
    Atherosclerosis; 1995 Jan; 112(2):187-95. PubMed ID: 7772078
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of apolipoprotein B-derived radical and alpha-tocopheroxyl radical in peroxidase-dependent oxidation of low density lipoprotein.
    Kalyanaraman B; Darley-Usmar V; Struck A; Hogg N; Parthasarathy S
    J Lipid Res; 1995 May; 36(5):1037-45. PubMed ID: 7658151
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alpha-tocopherol supplementation decreases the oxidative susceptibility of LDL in renal failure patients on dialysis therapy.
    Islam KN; O'Byrne D; Devaraj S; Palmer B; Grundy SM; Jialal I
    Atherosclerosis; 2000 May; 150(1):217-24. PubMed ID: 10781654
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro lipid peroxidation of LDL from postmenopausal cynomolgus macaques treated with female hormones.
    Schwenke DC; Wagner JD; Adams MR
    J Lipid Res; 1999 Feb; 40(2):235-44. PubMed ID: 9925652
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Copper-induced LDL peroxidation: interrelated dependencies of the kinetics on the concentrations of copper, hydroperoxides and tocopherol.
    Pinchuk I; Lichtenberg D
    FEBS Lett; 1999 May; 450(3):186-90. PubMed ID: 10359072
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of LDL trap assay to other tests of antioxidant capacity; effect of vitamin E and lovastatin treatment.
    Malminiemi K; Palomäki A; Malminiemi O
    Free Radic Res; 2000 Nov; 33(5):581-93. PubMed ID: 11200090
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Factors affecting resistance of low density lipoproteins to oxidation.
    Ziouzenkova O; Gieseg SP; Ramos P; Esterbauer H
    Lipids; 1996 Mar; 31 Suppl():S71-6. PubMed ID: 8729097
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mangostin inhibits the oxidative modification of human low density lipoprotein.
    Williams P; Ongsakul M; Proudfoot J; Croft K; Beilin L
    Free Radic Res; 1995 Aug; 23(2):175-84. PubMed ID: 7581813
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of antioxidant activity of epigallocatechin gallate in biphasic model systems in vitro.
    Hu C; Kitts DD
    Mol Cell Biochem; 2001 Feb; 218(1-2):147-55. PubMed ID: 11330830
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protein hydroperoxides are a major product of low density lipoprotein oxidation during copper, peroxyl radical and macrophage-mediated oxidation.
    Gieseg SP; Pearson J; Firth CA
    Free Radic Res; 2003 Sep; 37(9):983-91. PubMed ID: 14670006
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thiosemicarbazone derivate protects from AAPH and Cu2+ -induced LDL oxidation.
    Barcelos RP; Portella Rde L; da Rosa EJ; Fonseca Ade S; Bresolin L; Carratu V; Soares FA; Barbosa NV
    Life Sci; 2011 Jul; 89(1-2):20-8. PubMed ID: 21620869
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cosupplementation with coenzyme Q prevents the prooxidant effect of alpha-tocopherol and increases the resistance of LDL to transition metal-dependent oxidation initiation.
    Thomas SR; Neuzil J; Stocker R
    Arterioscler Thromb Vasc Biol; 1996 May; 16(5):687-96. PubMed ID: 8963727
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A randomized, single-blind, placebo-controlled trial of the effects of 200 mg alpha-tocopherol on the oxidation resistance of atherogenic lipoproteins.
    Porkkala-Sarataho EK; Nyyssönen MK; Kaikkonen JE; Poulsen HE; Hayn EM; Salonen RM; Salonen JT
    Am J Clin Nutr; 1998 Nov; 68(5):1034-41. PubMed ID: 9808219
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of the oxidative modification of LDL by nitecapone.
    Pentikäinen MO; Lindstedt KA; Kovanen PT
    Arterioscler Thromb Vasc Biol; 1995 Jun; 15(6):740-7. PubMed ID: 7773727
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lycopene synergistically inhibits LDL oxidation in combination with vitamin E, glabridin, rosmarinic acid, carnosic acid, or garlic.
    Fuhrman B; Volkova N; Rosenblat M; Aviram M
    Antioxid Redox Signal; 2000; 2(3):491-506. PubMed ID: 11229363
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of alpha- tocopherol on the velocity of low density lipoprotein oxidation by cupric ions.
    Ghaffari MA; Ghiasvand T
    Acta Med Iran; 2010; 48(5):289-94. PubMed ID: 21287459
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prooxidant and antioxidant properties of human serum ultrafiltrates toward LDL: important role of uric acid.
    Patterson RA; Horsley ET; Leake DS
    J Lipid Res; 2003 Mar; 44(3):512-21. PubMed ID: 12562831
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of peroxyl radical-mediated lipid oxidation by plasmalogen phospholipids and alpha-tocopherol.
    Hahnel D; Beyer K; Engelmann B
    Free Radic Biol Med; 1999 Nov; 27(9-10):1087-94. PubMed ID: 10569641
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vitamin E, LDL, and endothelium. Brief oral vitamin supplementation prevents oxidized LDL-mediated vascular injury in vitro.
    Belcher JD; Balla J; Balla G; Jacobs DR; Gross M; Jacob HS; Vercellotti GM
    Arterioscler Thromb; 1993 Dec; 13(12):1779-89. PubMed ID: 8241098
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Making vitamin C lipophilic enhances its protective effect against free radical induced peroxidation of low density lipoprotein.
    Liu ZQ; Ma LP; Liu ZL
    Chem Phys Lipids; 1998 Sep; 95(1):49-57. PubMed ID: 9807809
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.